Electrocardiographic data (n = 150) | Subject > 50 years (n = 49) | |
Left ventricular hypertrophy | 81 (54%) | 22 (44.8%) |
Left atrial hypertrophy | 48 (32%) | 16 (32.6%) |
Right ventricular hypertrophy | 6 (4%) | 2 (4%) |
Right atrial hypertrophy | 4 (2.6%) | 2 (4%) |
Atrial fibrillation | 49 (32.6%) | 17 (34.6%) |
Atrial flutter | 6 (4%) | 3 (6.1%) |
Supraventricular tachycardia | 2 (1.3%) | 1 (2%) |
Cardiac ischemia | 12 (8%) | 8 (16.3%) |
Echocardiographic data (n = 124) | Subject > 50 years (n = 39) | |
Left ventricular dilatation | 27 (21.7%) | 7 (17.9%) |
Left atrium dilation | 60 (48.3%) | 12 (30.6%) |
Right ventricular dilatation | 46 (37.1%) | 14 (35.8%) |
Right atrium dilation | 37 (29.8%) | 14 (35.8%) |
PAH between 35 - 50 mmHg | 41 (33%) | 9 (23%) |
PAH between 50 - 60 mmHg | 22 (17.7%) | 9 (23%) |
PAH > 60 mmHg | 8 (6.4%) | 2 (5.1%) |
Mitral valve insufficiency | 48 (38.7%) | 11 (28.2%) |
Tricuspid valve insufficiency | 42 (33.8%) | 12 (30.6%) |
Aortic valve insufficiency | 17 (13.7%) | 4 (10.2%) |
Pulmonary valve insufficiency | 2 (1.6%) | 0 (0%) |
left ventricular ejection impairment | 23 (18.5%) | 7 (17.9%) |
Pericardial effusion | 4 (3.2%) | 2 (5.1%) |